Skip to main content icon/video/no-internet

The world's second leading infectious cause of blindness, onchocerciasis affects 17.7 million people, 99 percent of whom live in Africa. A parasitic disease caused by the filiarial worm, Onchocerca volvulus, onchocerciasis is transmitted from human to human through the bite of infected Simulium black flies. The disease is most intensely transmitted among impoverished populations, primarily in rural African villages located near rapidly flowing streams, giving onchocerciasis its common name of “river blindness.”

Biological Impact

Onchocerciasis is caused when the body reacts to the presence of microscopic forms of O. volvulus. These worms can live under the skin and in other tissues for up to 14 years. As the worms grow, they mate and reproduce, spreading millions of new microfiliariae to other parts of the body. Itching, rashes, as well as skin depigmentation and nodules can develop as microfiliariae find loci in which to settle and grow. The most destructive consequence, however, is blindness, which is caused by long-term growth of O. volvulus in parts of the eye.

Social Impact

As a chronic infection, onchocerciasis inflicts severe social problems upon its victims.

People with the disease often suffer severe disability, especially blindness, and frequently are unable to work. Fearful of this most extreme manifestation, communities have often abandoned highly fertile areas of soil based near rivers. This trend has impeded social and economic development in badly hit rural areas of Africa.

Prevention, Treatment, and Control

Prevention and control measures against onchocerciasis include insecticide spraying to control blackflies. For instance, in West Africa, a World Health Organization-sponsored control program was able to widely reduce onchocerciasis by applying insecticides via aerial spraying over breeding sites of Simulium blackflies near fast-flowing rivers. However, given the long life cycle of the O. volvulus worms, these control efforts have failed at eradicating the disease in other parts of Africa. Thus, in 1995, the World Health Organization launched an Africa program to eliminate onchocerciasis by creating sustainable distribution systems, within communities, that would deliver ivermectin, a highly effective treatment, to at-risk and infected individuals. These efforts will eventually cover 59 million people throughout Africa. The goals of this campaign are to eliminate onchocerciasis as a serious public health problem and alleviate the social and economic hardships in individuals suffering from onchocerciasis-induced disability.

  • onchocerciasis
RajeshPanjabi, MPHUniversity of North Carolina–Chapel Hill

Bibliography

Division of Parasitic Diseases at the Centers for Disease Control and Prevention, “Onchocerciasis,”http://www.cdc.gov/Ncidod/dpd/ (cited October 2006)
J. K.Lazdins-Helds, J. H. F. Remme, and B. Boakye, “Onchocerciasis,”Nature Reviews Microbiology (v.1, 2003) http://dx.doi.org/10.1038/nrmicro779
The World Health Organization Special Programme for Research and Training in Tropical Diseases, “Onchocerciasis Disease Information,”http://www.who.int/tdr (cited October 2006).
  • Loading...
locked icon

Sign in to access this content

Get a 30 day FREE TRIAL

  • Watch videos from a variety of sources bringing classroom topics to life
  • Read modern, diverse business cases
  • Explore hundreds of books and reference titles

Sage Recommends

We found other relevant content for you on other Sage platforms.

Loading